Overview
AstraZeneca Pharma India Limited (APIL) is a subsidiary engaged in manufacturing, distributing, and marketing pharmaceutical products, focusing on therapeutic areas like oncology, cardio metabolic, and respiratory care.
The company has aligned with AstraZeneca PLC’s global therapeutic focus, driving significant market presence in India’s diabetes and cardiovascular segments through strategic partnerships and product launches.
APIL's recent launch of innovative drugs like Transtuzumab Deruxtecan for breast cancer marks its significant entry into advanced oncology treatment.
While regulatory interventions have influenced drug pricing, strategic responses like partnerships with Dr. Reddy's Laboratories and Sun Pharma enhanced APIL’s market access and portfolio reach.
APIL continues its R&D expansion in Bangalore, reinforcing its role within AstraZeneca’s global research network.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
20,543 Cr
- Volatility
Low Risk
- P/E Ratio
102.3
- Industry P/E
33.2
- PEG Ratio
4.2
- P/B Ratio
25.7
- 52W High
10,653.05
- 52W Low
6,501.60
Financial Ratios
Sales CAGR
- 1Y
- 32.48%
- 3Y
- 28.67%
- 5Y
- 15.59%
- 10Y
- 13.03%
Profit CAGR
- 1Y
- -28.34%
- 3Y
- 23.40%
- 5Y
- 9.89%
- 10Y
- 40.99%
ROE
- TTM
- 28.93%
- 3Y
- 18.18%
- 5Y
- 17.49%
- 10Y
- 16.38%
ROCE
- TTM
- 37.48%
- 3Y
- 24.02%
- 5Y
- 23.16%
- 10Y
- 22.37%
Technicals
Oscillators
Neutral
Bearish
2
Neutral
7
Bullish
5
Overall
Bearish
Bearish
29
Neutral
7
Bullish
10
Moving Averages
Bearish
Bearish
27
Neutral
0
Bullish
5
Documents
Investor Presentation
Q1 FY24
Investor Presentation
Q1 FY23
Investor Presentation
Q1 FY22
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY21
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY19
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
